Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2006 1
2011 2
2014 1
2015 2
2017 2
2018 2
2019 3
2020 1
2021 3
2022 2
2023 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study.
Topp MS, Matasar M, Allan JN, Ansell SM, Barnes JA, Arnason JE, Michot JM, Goldschmidt N, O'Brien SM, Abadi U, Avivi I, Cheng Y, Flink DM, Zhu M, Brouwer-Visser J, Chaudhry A, Mohamed H, Ambati S, Crombie JL. Topp MS, et al. Among authors: abadi u. Blood. 2025 Apr 3;145(14):1498-1509. doi: 10.1182/blood.2024027044. Blood. 2025. PMID: 39786390 Free PMC article. Clinical Trial.
Leukemia and lymphoma in pregnancy.
Abadi U, Koren G, Lishner M. Abadi U, et al. Hematol Oncol Clin North Am. 2011 Apr;25(2):277-91, vii. doi: 10.1016/j.hoc.2011.01.001. Hematol Oncol Clin North Am. 2011. PMID: 21444030 Review.
The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in patients with lymphoma.
Zoref-Lorenz A, Murakami J, Gurion R, Iyer SP, Abadi U, Cohen I, Goyal G, Mohamed S, Nikiforow S, Natour AEH, Weinstein S, Yacobovich J, Cho HL, Raanani P, Nagler A, Berliner N, Daver N, Itchaki G, Izraeli S, Ellis M, Jordan MB. Zoref-Lorenz A, et al. Among authors: abadi u. Blood Adv. 2025 Sep 9;9(17):4515-4525. doi: 10.1182/bloodadvances.2024014005. Blood Adv. 2025. PMID: 40249910 Free PMC article.
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Avivi I, Perry C, Segman Y, Amit O, Bar-On Y, Katz OB, Gold R, Ribakovsky E, Avigdor A, Vainstein V, Goldschmidt N, Ringelstein-Harlev S, Horowitz NA, Gutwein O, Gurion R, Itchaki G, Abadi U, Nemets A, Sofer O, Vezker M, Tadmor T, Dally N, Filanovsky K, Leiba M, Sarid N, Benyamini N, Luttwak E, Herishanu Y, Ram R. Avivi I, et al. Among authors: abadi u. Ann Hematol. 2022 Apr;101(4):755-762. doi: 10.1007/s00277-021-04749-9. Epub 2022 Jan 27. Ann Hematol. 2022. PMID: 35083525
Myositis in Behcet's disease after tonsillectomy.
Abadi U, Hadary R, Shilo L, Shabun A, Greenberg G, Kovatz S. Abadi U, et al. Isr Med Assoc J. 2006 Apr;8(4):294-5. Isr Med Assoc J. 2006. PMID: 16671372 Free article. No abstract available.
20 results